United States · Series B startup

Who invested in Labviva

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$25Mraised across 1 round since 2025, from 1 source

Latest round
Series B, $25MJan 2025
Investors
4
See who backed them

The rounds

  1. Jan 2025

Founders and team

From the SEC filings it signed: 3 on the team.

  • Aaron MiramontesExecutive Officeri
  • Nicholas RiouxExecutive Officer, Directori
  • Siamak BaharlooExecutive Officer, Directori

On the board, as filediEvan LodesSarah Fay

Everyone who backed them

B CapitalVC firm1round
Village GlobalVC firm1round
MassVenturesVC firm1round
Glasswing VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Labviva as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

53 StationsCorporate VCPer its own site
SeedFolioVC firmPer its own site

Quick answers about Labviva

Who invested in Labviva?

Labviva's investors include B Capital, Village Global, MassVentures and Glasswing Ventures.

How much has Labviva raised?

Labviva has raised $25M across 1 round since 2025.

When did Labviva last raise?

Labviva's most recent round was a Series B of $25M in Jan 2025.

What was Labviva's biggest round?

Its most recent round, $25M in Jan 2025, is also its largest on record.

Who backed Labviva first?

Labviva's first round on record, in Jan 2025, was backed by B Capital, Village Global and MassVentures and 1 others.

What stage is Labviva at?

Labviva's latest named round is a Series B, in Jan 2025.

Where is Labviva based?

Labviva is based in the United States.

Companies like Labviva

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.